Disadvantages include instability, high costs, and need for injections , but ongoing innovations aim to overcome these barriers
Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
Hayes, D
Peptide therapy might be worth considering if you are experiencing chronic fatigue or brain fog that affects your quality of life, inflammatory conditions that are not responding well to conventional care, autoimmune flares that keep returning, digestive issues or slow healing, early signs of cognitive decline, or the sense that you are not aging as well as you would like
This ensures that more bioavailable glutathione reaches your cells, amplifying its effectiveness and delivering profound health benefits